Pharmacological inhibition of the mitochondrial NADPH oxidase 4/PKC/Gal-3 signaling pathway attenuates adverse cardiac fibrosis, following myocardial infarction
25 August 2018 (11:00 - 16:00)
Organised by:
Abstract
About the speaker
Virgen de la Arrixaca University Clinical Hospital, Murcia (Spain)
9 More presentations in this session
Access the full session
The Event
ESC Congress 2018
25 August 2018
11:00 CET
You may be interested in
Congress Session
Congress Session
